This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Therapeutic or Experimental Procedure?

Peter C. Dau, MD

Arch Neurol. 1984;41(6):647-653.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

As in other areas of medicine that are in flux because of rapidly accumulating knowledge, most plasmapheresis therapy procedures have not yet solidified into routine clinical practice. The apparent controversies engendered by such a state of affairs tend gradually to fade away as a broader base of experience with the new technology forms within the medical community. It appears that plasmapheresis therapy is becoming accepted in the treatment of some neurologic diseases, but in most instances it probably has considerable unexploited potential. In this report I have attempted to summarize current knowledge about plasmapheresis therapy in neurology.

MYASTHENIA GRAVIS (MG)

The beneficial effects of plasmapheresis in MG and the excellent inverse correlation between changes in clinical status and a change in the level of antibody to acetylcholine receptor (anti-AChR) were discovered independently by a group in London and by us in 1976 and 1977.^1-3 . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Medicine, Division of Allergy/Immunology, Evanston (Ill) Hospital, and the Department of Neurology, Northwestern University Medical School, Chicago.

Footnotes
Accepted for publication Dec 13, 1983.

Reprint requests to Division of Allergy/Immunology, Evanston Hospital, 2650 Ridge Ave, Evanston, IL 60201.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?